durvalumab
roche,astrazeneca,orpathys
['calypso', 'rcc,(-irccs),(-srcc),(-urcc)', 'car-t', '$rhhby', 'biotec']
great analysis as always! ccrcc calypso pd-1+cmeti trial: readhthru for cabo moa? capture of comments re: future combos (hif, lag-3). $rhhby making some nice progress fine tuning cd3 activity too? (or maybe 2x the cd20 post cd-19 car-t = 2x the fun?) #neat #asco22 
Biotech Buyside. Tweets are only opinion/speculation and not advice/solicitation. May be L/S names, consider conflicts.